Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient Centered Technologies to Improve Hemodialysis Vascular Access Cannulation.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Biofunctionalized Vascular Access Graft Improves Patency and Endothelialization in a Porcine Arteriovenous Model.

Journal of functional biomaterials·2026
Same author

Safety and Effectiveness of the Wrapsody Cell-Impermeable Endoprosthesis to Treat Dysfunctional Arteriovenous Grafts: Results from the Nonrandomized Arm of the WAVE Trial.

Journal of vascular and interventional radiology : JVIR·2026
Same author

One-Year Clinical Outcomes from the Randomized Controlled Arm of the Wrapsody Arteriovenous Access Efficacy (WAVE) Trial.

Journal of vascular and interventional radiology : JVIR·2026
Same author

NF-κB-driven lymphangiogenesis affects kidney function via a VEGFR-3-mediated pathway.

JCI insight·2026
Same author

Bulk RNA Sequencing Reveals Signature Differences in Key Cell Signaling Pathways Between Porcine Venous and Arterial Smooth Muscle Cells.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Jul 9, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Vascular stenosis: biology and interventions.

Prabir Roy-Chaudhury1, Timmy C Lee

  • 1Division of Nephrology and the Cincinnati Dialysis Access Research Program, University of Cincinnati, Cincinnati, Ohio 45267-0585, USA.

Current Opinion in Nephrology and Hypertension
|December 20, 2007
PubMed
Summary

Understanding dialysis access stenosis pathophysiology, focusing on adventitia and progenitor cells, can guide novel therapies. This review highlights interventions for arteriovenous fistula dysfunction in hemodialysis patients.

More Related Videos

A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure
07:02

A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure

Published on: May 15, 2020

Related Experiment Videos

Last Updated: Jul 9, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure
07:02

A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure

Published on: May 15, 2020

Area of Science:

  • Nephrology
  • Vascular Surgery
  • Biomedical Engineering

Background:

  • Dialysis access dysfunction is a major cause of morbidity and mortality in hemodialysis patients.
  • Arteriovenous fistulae are preferred for vascular access due to numerous advantages.
  • Understanding the pathophysiology of access stenosis is crucial for developing effective treatments.

Purpose of the Study:

  • To review recent concepts in the pathophysiology of dialysis access stenosis.
  • To highlight novel diagnostic and therapeutic interventions for dialysis access dysfunction.
  • To emphasize the role of the adventitia and progenitor cells in pathogenesis.

Main Methods:

  • Comprehensive review of experimental, observational studies, and clinical trials.
  • Focus on arteriovenous fistulae and local therapeutic interventions.
  • Analysis of biological mechanisms and interventional strategies.

Main Results:

  • Emphasis on the role of adventitia and progenitor cells in dialysis access dysfunction pathogenesis.
  • Highlighting access surveillance and local drug delivery as key interventions.
  • Underscoring the advantages of local therapeutic interventions for arteriovenous fistulae.

Conclusions:

  • Improved understanding of vascular access stenosis mechanisms is essential.
  • This knowledge will drive the development of novel therapies.
  • Novel therapies are needed to prevent and treat dialysis access stenosis, improving patient outcomes.